NDAINJECTIONINJECTABLE
Approved
May 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
OPTIRAY 240 (ioversol) by Guerbet is x-ray contrast activity [moa]. First approved in 1998.
Drug data last refreshed 17h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OPTIRAY 240 (ioversol) is a non-ionic, low-osmolality radiographic contrast agent administered by injection for diagnostic imaging procedures. It enhances visualization of vascular structures and organs during X-ray imaging in patients with renal impairment, coronary artery disease, diabetes mellitus, and hypothyroidism. The drug works by increasing radiopacity in target tissues to improve diagnostic image quality.
LOE Approaching
With LOE approaching and moderate competitive pressure (30), OPTIRAY 240 faces revenue erosion; brand team size likely stable or declining as resources shift to pipeline assets.
Mechanism of Action
X-Ray Contrast Activity
Pharmacologic Class:
Radiographic Contrast Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With zero linked jobs and LOE approaching, OPTIRAY 240 offers minimal career development opportunity; positions are likely being consolidated or eliminated as Guerbet optimizes its diagnostic contrast portfolio. Professionals on this team should prepare for transitions to growth-stage products or alternative roles within the organization.
Field Sales Representative
Worked on OPTIRAY 240 at Guerbet? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.